Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic

Lancet Oncol. 2020 May;21(5):624-627. doi: 10.1016/S1470-2045(20)30226-6. Epub 2020 Apr 8.
No abstract available

MeSH terms

  • COVID-19
  • Clinical Trials as Topic*
  • Colombia
  • Coronavirus Infections / epidemiology*
  • Government Agencies
  • Humans
  • Neoplasms / therapy*
  • Norway
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • United Kingdom
  • United States
  • United States Food and Drug Administration